Isotretinoin (oral formulations) : List of nationally authorised medicinal products - PSUSA/00010488/202305
Benzyl nicotinate/camphor/dimethyl sulfoxide/nonivamide/turpentine oil, Nicoboxil/ Nonivamide : List of nationally authorised medicinal products - PSUSA/00010584/202303
Methylphenobarbital : List of nationally authorised medicinal products - PSUSA/00002025/202303
Triamcinolone (intraocular formulations) : List of nationally authorised medicinal products - PSUSA/00010292/202303
Mometasone furoate/olopatadine : List of nationally authorised medicinal products - PSUSA/00010957/202304
human plasma (pooled and treated for virus inactivation) : List of nationally authorised medicinal products - PSUSA/00001635/202302
Plasma master file certificates
Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) Multistakeholder workshop on Patient Registries, European Medicines Agency, Amsterdam, the Netherlands, from 12/02/2024 to 13/02/2024
EMEA-002545-PIP01-19-M01
Opinion/decision on a Paediatric investigation plan (PIP): Atropine (sulfate), decision type: , therapeutic area: , PIP number: P/0416/2022